Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Jiangsu Walvax Biotech Co.

Latest From Jiangsu Walvax Biotech Co.

Study: FDA Data Shows Endoscope-Related Adverse Events Continue To Rise

A new review of adverse event data found reports tied to each of six endoscope categories rose significantly between 2014 and 2021. For gastroscopes, the rise was an eye-popping 8,630%.

Regulation Safety

Boston Scientific’s Single-Use Exalt-B Bronchoscope To Compete With Ambu’s aScope

Boston Scientific has received 510(k) clearance, launching it into a $1bn market where single-use scopes are increasingly recommended to prevent spread of infections.

Commercial Research & Development

FDA Recommends Broader Use Of Single-Use Bronchoscopes

The single-use scopes should be used in lieu of reprocessed devices when a significant infection risk exists, the US agency says.

Regulation Safety

Signs Of R&D Progress For GSK, Though China Overhang Remains

With four new drug approvals notched under its belt in four months, GlaxoSmithKline had several potential growth drivers to highlight during its third quarter earnings call, helping to deflect attention away from the bribery scandal in China.

BioPharmaceutical China
See All

Company Information